Mount Yale Investment Advisors LLC Cuts Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Mount Yale Investment Advisors LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.6% in the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,491 shares of the company’s stock after selling 122 shares during the period. Mount Yale Investment Advisors LLC’s holdings in HCA Healthcare were worth $1,443,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Bangor Savings Bank increased its position in shares of HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after purchasing an additional 45 shares during the last quarter. MFA Wealth Advisors LLC purchased a new stake in shares of HCA Healthcare in the second quarter valued at $27,000. Unique Wealth Strategies LLC purchased a new position in shares of HCA Healthcare during the 2nd quarter worth about $28,000. GPS Wealth Strategies Group LLC raised its position in HCA Healthcare by 284.0% in the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares during the period. Finally, LifeSteps Financial Inc. bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $33,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts recently issued reports on the company. StockNews.com upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Monday, July 1st. Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Robert W. Baird began coverage on shares of HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective for the company. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Five investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $359.89.

HCA Healthcare Stock Performance

Shares of HCA opened at $404.66 on Monday. HCA Healthcare, Inc. has a 12 month low of $215.96 and a 12 month high of $405.70. The stock has a fifty day moving average price of $370.57 and a 200-day moving average price of $340.70. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The firm has a market cap of $105.99 billion, a PE ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.97 by $0.53. The firm had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. The company’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $4.29 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Insiders Place Their Bets

In related news, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In related news, SVP Kathleen M. Whalen sold 2,987 shares of the stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,202 shares of company stock valued at $6,407,273. 1.60% of the stock is owned by insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.